Neuropsychological Development in Patients with Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency

Overview

Journal JIMD Rep

Publisher Wiley

Date 2015 Nov 8

PMID 26545880

Citations 8

Authors

A Strandqvist

C Bieneck Haglind

R H Zetterstrom

A Nemeth

U von Dobeln

M Halldin Stenlid

A Nordenstrom

Affiliations

Soon will be listed here.

Abstract

Background: Reports on cognitive outcomes in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) are scarce. We present results from neuropsychological assessments of eight patients diagnosed with LCHADD prior to newborn screening with regard to clinical disease severity.

Methods: Intellectual ability and adaptive and executive functions were assessed using age-appropriate Wechsler Scales, Adaptive Behavior Assessment Scales (ABAS), and Behavior Rating Inventory of Executive Function (BRIEF).

Results: Five patients performed in the normal range on IQ tests but with lower scores on verbal working memory. In addition, they had lower parent-rated adaptive and executive functions.Three patients had intellectual disabilities with IQs below normal and/or autism spectrum disorders. In addition, they had low results on parent-rated adaptive functions. (Two of these patients had epilepsy.) Conclusions: Patients with LCHADD seem to have a specific cognitive pattern, with presentation as intellectual disability and specific autistic deficiencies or a normal IQ with weaknesses in auditive verbal memory and adaptive and executive functions. Future studies are warranted to investigate whether newborn screening programs and early treatment may promote improved neuropsychological development and outcomes.

Citing Articles

The Role of Acyl-CoA β-Oxidation in Brain Metabolism and Neurodegenerative Diseases.

Szrok-Jurga S, Turyn J, Hebanowska A, Swierczynski J, Czumaj A, Sledzinski T Int J Mol Sci. 2023; 24(18).

PMID: 37762279 PMC: 10531288. DOI: 10.3390/ijms241813977.

Very long-chain acyl-CoA dehydrogenase deficiency in a Swedish cohort: Clinical symptoms, newborn screening, enzyme activity, and genetics.

Olsson D, Barbaro M, Haglind C, Halldin M, Lajic S, Tucci S JIMD Rep. 2022; 63(2):181-190.

PMID: 35281659 PMC: 8898720. DOI: 10.1002/jmd2.12268.

Diagnosis and Clinical Management of Long-chain Fatty-acid Oxidation Disorders: A Review.

Baker J, Burton B touchREV Endocrinol. 2022; 17(2):108-111.

PMID: 35118456 PMC: 8676101. DOI: 10.17925/EE.2021.17.2.108.

Mitochondrial Fatty Acid β-Oxidation and Resveratrol Effect in Fibroblasts from Patients with Autism Spectrum Disorder.

Barone R, Bastin J, Djouadi F, Singh I, Karim M, Ammanamanchi A J Pers Med. 2021; 11(6).

PMID: 34199819 PMC: 8229571. DOI: 10.3390/jpm11060510.

Clinical manifestations and management of fatty acid oxidation disorders.

Merritt 2nd J, MacLeod E, Jurecka A, Hainline B Rev Endocr Metab Disord. 2020; 21(4):479-493.

PMID: 32654032 PMC: 7560910. DOI: 10.1007/s11154-020-09568-3.

References

Hsu H, Zytkovicz T, Marie Comeau A, Strauss A, Marsden D, Shih V . Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening. Pediatrics. 2008; 121(5):e1108-14. DOI: 10.1542/peds.2007-1993. View

Cryan J, Dinan T . Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012; 13(10):701-12. DOI: 10.1038/nrn3346. View

Haglind C, Stenlid M, Ask S, Alm J, Nemeth A, Dobeln U . Growth in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. JIMD Rep. 2013; 8:81-90. PMC: 3565647. DOI: 10.1007/8904_2012_164. View

Manzi B, Loizzo A, Giana G, Curatolo P . Autism and metabolic diseases. J Child Neurol. 2007; 23(3):307-14. DOI: 10.1177/0883073807308698. View

Clark-Taylor T, Clark-Taylor B . Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. Med Hypotheses. 2004; 62(6):970-5. DOI: 10.1016/j.mehy.2004.01.011. View

Fletcher A, Pennesi M, Harding C, Weleber R, Gillingham M . Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies. Mol Genet Metab. 2012; 106(1):18-24. PMC: 3506186. DOI: 10.1016/j.ymgme.2012.02.015. View

Harding C, Gillingham M, Van Calcar S, Wolff J, Verhoeve J, Mills M . Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1999; 22(3):276-80. PMC: 2694039. DOI: 10.1023/a:1005502626406. View

Angelidou A, Asadi S, Alysandratos K, Karagkouni A, Kourembanas S, Theoharides T . Perinatal stress, brain inflammation and risk of autism-review and proposal. BMC Pediatr. 2012; 12:89. PMC: 3496584. DOI: 10.1186/1471-2431-12-89. View

Rossignol D, Frye R . Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2011; 17(3):290-314. PMC: 3285768. DOI: 10.1038/mp.2010.136. View

10.

Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman C, Reichenberg A . The familial risk of autism. JAMA. 2014; 311(17):1770-7. PMC: 4381277. DOI: 10.1001/jama.2014.4144. View

11.

den Boer M, Wanders R, Morris A, Ijlst L, Heymans H, Wijburg F . Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics. 2002; 109(1):99-104. DOI: 10.1542/peds.109.1.99. View

12.

Svennerholm L . Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res. 1968; 9(5):570-9. View

13.

German O, Monaco S, Agnolazza D, Rotstein N, Politi L . Retinoid X receptor activation is essential for docosahexaenoic acid protection of retina photoreceptors. J Lipid Res. 2013; 54(8):2236-2246. PMC: 3708373. DOI: 10.1194/jlr.M039040. View

14.

Heaton A, Meldrum S, Foster J, Prescott S, Simmer K . Does docosahexaenoic acid supplementation in term infants enhance neurocognitive functioning in infancy?. Front Hum Neurosci. 2013; 7:774. PMC: 3834239. DOI: 10.3389/fnhum.2013.00774. View

15.

Olpin S, Clark S, Andresen B, Bischoff C, Olsen R, Gregersen N . Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency. J Inherit Metab Dis. 2005; 28(4):533-44. DOI: 10.1007/s10545-005-0533-8. View

16.

Cox G, Souri M, Aoyama T, Rockenmacher S, Varvogli L, Rohr F . Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr. 1998; 133(2):247-53. DOI: 10.1016/s0022-3476(98)70228-8. View

17.

Iafolla A, Thompson Jr R, Roe C . Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr. 1994; 124(3):409-15. DOI: 10.1016/s0022-3476(94)70363-9. View

18.

Bakermans A, Geraedts T, van Weeghel M, Denis S, Ferraz M, Aerts J . Fasting-induced myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice is accompanied by impaired left ventricular function. Circ Cardiovasc Imaging. 2011; 4(5):558-65. DOI: 10.1161/CIRCIMAGING.111.963751. View

19.

Brown A, Crowe L, Andresen B, Anderson V, Boneh A . Neurodevelopmental profiles of children with very long chain acyl-CoA dehydrogenase deficiency diagnosed by newborn screening. Mol Genet Metab. 2014; 113(4):278-82. DOI: 10.1016/j.ymgme.2014.10.005. View

20.

Carver J, Benford V, Han B, Cantor A . The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res Bull. 2001; 56(2):79-85. DOI: 10.1016/s0361-9230(01)00551-2. View